UroMems champions positive results for stress urinary incontinence implant

UroMems has reported more positive results from a trial evaluating its UroActive device for the treatment of stress urinary incontinence. The France-headquartered company stated the...

AiM Medical Robotics, BWH partner on robotic deep brain stimulation study

AiM Medical Robotics announced a collaboration with Brigham and Women’s Hospital (BWH) to validate its robot for deep brain stimulation (DBS). The company and...

HeartBeam’s AI device outperforms experts in detecting atrial flutter 

HeartBeam has presented data demonstrating that its HeartBeam AI applied to vectorcardiography (VCG) technology outperformed an expert panel of heart rhythm cardiologists in detecting...

CathRx says first-in-human data backs pulsed field ablation tech

CathRx announced that results from its first-in-human study support its ElectroPulse pulsed field ablation (PFA) system. The Sydney, Australia-based company, which just emerged from...

Elixir’s focal stress system to treat calcified lesions hits success in trial

Elixir Medical has reported positive data from the PINNACLE I clinical trial evaluating the safety and effectiveness of its catheter system that uses stress...

Thermedical completes feasibility study to use SERF with PFA

Thermedical announced today that it completed a feasibility study using pulsed field ablation in combination with its SERF ablation system.Weston, Massachusetts–based Thermedical designed its...

Study finds intravascular imaging effective for imaging the brain

US-based intravascular imaging and artificial intelligence (AI) company, Spryte Medical, has announced the publication of the first clinical study of its neuro Optical Coherence...

Farapulse founder’s Field Medical begins first-in-human pulsed field ablation trial

Field Medical announced that it began the first-in-human study of its FieldForce pulsed field ablation (PFA) system. The company began its study evaluating FieldForce...

Innosphere starts paediatric clinical trial for Novostim ADHD device

German device company Innosphere Engineering has started recruitment for the clinical trial for its attention deficit hyperactivity disorder (ADHD) device, Novostim 2. The randomised, sham-controlled...

Latest articles